PARASAL
Pre-Launchaminosalicylic acid
NDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
2
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PARASAL (aminosalicylic acid) is an oral tablet small molecule in pre-launch stage with an NDA approval pathway. Aminosalicylic acid is a salicylate compound historically used in tuberculosis treatment and other infectious/inflammatory conditions. The exact current indication(s) and mechanism of action are not specified in available data.
Pre-Launch
Pre-launch stage indicates early-stage commercial infrastructure build with growing team demand across regulatory affairs, market access, and field readiness roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea
Started Oct 2021
11,385 enrolled
Ulcerative Colitis
Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)
Started Jan 2012
510 enrolled
Ulcerative Colitis
Career Relevance
PARASAL is in pre-launch phase with zero current linked job openings, but upcoming approval will trigger hiring across regulatory, medical, and commercial functions. Working on this product offers early-stage career opportunity to build a specialty infectious disease franchise from launch.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.